Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review by Lu Wang, Xueting Wang, Motong Xu, Yanan Wang, Lingxin Feng, Xue Yang, Jing Wang

Subjects: Get full text

De Novo EGFR ‐ALK and EGFR ‐ROS1 Co‐Mutations in NSCLC: Clinical Characteristics, Molecular Profiling, and Treatment Outcomes From a Retrospective Analysis by Lili Shen, Hongyu Deng, Wei Liao, Qiang Gu, Lingling Ma, Qingming Jiang, Kaihua Liu

Subjects: Get full text

A Case Report of Coexistence of EGFR and ROS-1 Gene Mutations 
in Non-small Cell Lung Cancer by Juan ZHAO, Jiaofeng YU, Ye FU, Yan ZHAO, Mingli ZHAO

Subjects: Get full text

The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis by Rui Zhao, Yang Shu, Wei Xu, Fengxian Jiang, Pancen Ran, Liying Pan, Jingliang Wang, Weihao Wang, Jing Zhao, Yahui Wang, Guobin Fu

Subjects: Get full text

Prognostic Significance of KMT2D Gene Mutation and Its Co-mutated Genes in Patients with Diffuse Large B-Cell Lymphoma by Mutibaier·MIJITI, Xiaolong QI, Renaguli·ABULAITI, Wenxin TIAN, Sha LIU, Weiyuan MA, Zengsheng WANG, Li AN, Min MAO, Muhebaier·ABUDUER, Yan LI

Subjects: Get full text

Clinical characteristics and treatment management of combined large cell neuroendocrine carcinoma, a subtype of large cell neuroendocrine carcinoma by Kai Kang, Binfeng Li, Sheng Wang, Jianjian Wang, Xinjun Liang

Subjects: Get full text

Anti-tumor immune modulation and favorable survival outcomes in uterine corpus endometrial carcinoma: insights from PIK3CA/ARID1A co-mutation analysis by Dongmei Han, Caihong Wu, Hao Jin

Subjects: Get full text

A systematic literature review of MTAP deletions in solid and hematologic Cancers by Mary C. Clouser, Mina Suh, Naimisha Movva, Janet S. Hildebrand, Susan T. Pastula, Martina Schoehl, Antreas Hindoyan, Akhila Balasubramanian, Jon P. Fryzek, Soo-Ryum Yang

Subjects: Get full text

Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer by K. K. Laktionov, A. M. Kazakov, K. A. Sarantseva, D. S. Scherbo, A. P. Koval

Subjects: Get full text

Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer by Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, Hélène Blons, Rym BenDhiab, Laure Gibault, Elizabeth Fabre

Subjects: Get full text